AstraZeneca’s Imfinzi (durvalumab) has been recommended by NICE for use [...]

Grow Therapy has published its first peer-reviewed outcomes study, reporting [...]

Incannex Healthcare has said its PSX-001 oral synthetic psilocybin programme [...]

Japan’s push to modernise clinical research through artificial intelligence and [...]

Remepy has announced a collaboration with Merck KGaA, Darmstadt Germany, [...]

RxLogix has launched a new version of its PVOne.AI platform [...]

Intellia Therapeutics has reported positive Phase 3 results for lonvoguran [...]

Nature publishes Phase 1b data showing NETRIS Pharma’s NP137 improves [...]

Myomaker Bio, a UK biotechnology company spun out from Loughborough [...]

Abivax will present nine scientific abstracts on obefazimod at Digestive [...]